<it>Bacillus Coagulans </it>GBI-30 (BC30) improves indices of <it>Clostridium difficile</it>-Induced colitis in mice
<p>Abstract</p> <p>Background</p> <p>Probiotics have beneficial effects in rodent models of <it>Clostridium difficile </it>(<it>C. diffiicle</it>)-induced colitis. The spore forming probiotic strain <it>Bacillus Coagulans </it>GBI-30,...
Main Authors: | Fitzpatrick Leo R, Small Jeffrey S, Greene Wallace H, Karpa Kelly D, Keller David |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | Gut Pathogens |
Subjects: | |
Online Access: | http://www.gutpathogens.com/content/3/1/16 |
Similar Items
-
<it>Bacillus coagulans</it> GBI-30, 6086 limits the recurrence of <it>Clostridium difficile</it>-Induced colitis following vancomycin withdrawal in mice
by: Fitzpatrick Leo R, et al.
Published: (2012-10-01) -
Intravenous immunoglobulin in the treatment of severe Clostridium difficile colitis
by: Nihar Shah, et al.
Published: (2014-01-01) -
Tigecycline for severe Clostridium difficile infection
by: Ashley Thomas, et al.
Published: (2014-09-01) -
Clinical predictors of fulminant colitis in patients with Clostridium difficile infection
by: Mohit Girotra, et al.
Published: (2012-01-01) -
Hemolytic uremic syndrome and Clostridium difficile colitis
by: Maryam Keshtkar-Jahromi, et al.
Published: (2012-10-01)